En bloc resection, is this the future of non-muscle invasive bladder cancer management? Presentation of our technique and brief review of the literature.


Journal

Urologia
ISSN: 1724-6075
Titre abrégé: Urologia
Pays: United States
ID NLM: 0417372

Informations de publication

Date de publication:
Feb 2023
Historique:
medline: 5 4 2023
pubmed: 26 4 2022
entrez: 25 4 2022
Statut: ppublish

Résumé

The quality of the initial transurethral resection of bladder tumors (TURBT) plays a key role in accurate local staging thus affecting treatment decision-making and disease prognosis. TURBT is still the gold standard for non-muscle invasive bladder cancer (NMIBC). However, en bloc resection of bladder tumors (ERBT) gradually expanded as a promising alternative to TURBT, aiming to overcome certain inherent limitations of conventional resection. We hereby describe a step-by-step bipolar ERBT technique and briefly review the current trends surrounding the role of various en bloc techniques in the field. We present the case of a 65-year old patient undergoing bipolar ERBT for a single, approximately 2 cm, papillary bladder mass. An experienced urologist completed the procedure within 17 min and without any intra- or postoperative complications. No conversion to TURBT was needed, and an adequate specimen for histological assessment was obtained. The patient made an uneventful recovery, and no recurrence was noted at 12-months. Our initial experience demonstrates that ERBT via bipolar current is relatively quick, safe, and reliable. Prospective comparative clinical trials will examine its efficacy, and long-term oncological superiority in managing NMIBC.

Identifiants

pubmed: 35467455
doi: 10.1177/03915603221093739
doi:

Types de publication

Review Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

75-79

Auteurs

Evangelos N Symeonidis (EN)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Panagiotis Baniotis (P)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Georgios Langas (G)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Panagiotis Stefanidis (P)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Stavros Tsiakaras (S)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Michail Stratis (M)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Eliophotos Savvides (E)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Athanasios Bouchalakis (A)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Stefanos Petras (S)

Department of Pathology, "G. Gennimatas" General Hospital, Thessaloniki, Greece.

Dimitrios Memmos (D)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Anastasios Anastasiadis (A)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Ioannis Mykoniatis (I)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Ioannis Vakalopoulos (I)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Chrysovalantis Toutziaris (C)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Georgios Dimitriadis (G)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Petros Sountoulides (P)

First Department of Urology, School of Medicine, "G. Gennimatas" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH